L'Oréal has reported stellar trading for the first half of 2026, with its dermatological division, housing CeraVe and Vichy, driving bumper sales. The bumper sales growth helped offset the impact on demand in the Gulf region due to the ongoing war in Iran, except Saudi Arabia. La Roche-Posay benefited from continued sales of Cicaplast, coupled with successful launches like Hyalu B5 Suractivated and UV Air Fluid. Consumer Products division sees single-digit but consistent salesColor WowL'Oréal’s Consumer Products reported a like-for-like sales increase of 2.4%, to €4.27bn. L'Oréal Luxe benefits from strong China demandVichyL'Oréal’s Luxe division sales hit €3.8bn in H1, a 5.7% increase on a like-for-like basis.